Meditation to Reduce Stress and Improve Quality of Life

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dietlind Wahner-Roedler, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01047917
First received: January 11, 2010
Last updated: January 4, 2012
Last verified: January 2012

January 11, 2010
January 4, 2012
March 2008
April 2008   (final data collection date for primary outcome measure)
To assess the feasibility of incorporating a 4-week innovative meditation program into the daily activities of healthy Mayo Clinic employees for improving stress. [ Time Frame: 4 Weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01047917 on ClinicalTrials.gov Archive Site
To assess the effect of a 4-week program of meditation on perceived stress and overall quality of life compared to baseline. [ Time Frame: 4 Weeks ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Meditation to Reduce Stress and Improve Quality of Life
Meditation to Reduce Stress and Improve Quality of Life: A Feasibility Study

The purpose of this study is to test a simple meditation program that is easy to learn; inexpensive; easy to practice; non-religion based; and has wide applicability to multiple medical conditions. This program has been developed by the Complementary and Integrative Medicine Program at the Mayo Clinic.

Stress is a ubiquitous problem and a mediator of symptoms for a variety of medical conditions. Most medical diagnoses, procedures, and physician visits are associated with considerable stress. Excessive stress is associated with adverse medical outcomes, unhealthy coping mechanisms, symptoms of anxiety and depression, and overall a poor quality of life. No specific pharmacologic treatment is available for treating stress. Further, it is often difficult or impossible to change the reality of circumstances causing stress in an individual. Thus increasing individual coping mechanisms and ability of a person to handle stress, rather than changing the stressors itself, might be a more feasible approach towards reducing stress.

Meditation is a widely used and increasingly popular intervention that positively affects the individual at cognitive, physical, emotional, behavioral, and spiritual levels. A practice of meditation has been shown to reduce symptoms of stress and improve overall quality of life. Several meditation programs exist, however most are limited by considerable expense, need for elaborate training, lack of widespread availability, or incorporation of ideas and practices unique to a particular culture.

Interventional
Not Provided
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Stress
Behavioral: Meditation DVD
Participants will undergo a one-hour group instruction session in meditation held by Dr. Amit Sood. Participants will then receive a DVD to practice the intervention at home daily for a total of 4 weeks. The DVD will have 3 different programs of 5, 15, and 30 minutes each loaded on it with a menu option to choose one of the programs.
Other Name: Meditation
Experimental: Meditation DVD
All participants will receive a Meditation DVD to practice at home daily for a total of 4 weeks.
Intervention: Behavioral: Meditation DVD
Prasad K, Wahner-Roedler DL, Cha SS, Sood A. Effect of a single-session meditation training to reduce stress and improve quality of life among health care professionals: a "dose-ranging" feasibility study. Altern Ther Health Med. 2011 May-Jun;17(3):46-9.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
17
April 2008
April 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • At least 18 years of age
  • Good general health
  • Access to a DVD player
  • Provided with, understand, and have signed the informed consent

Exclusion Criteria:

  • Are currently using (at the time of enrollment) antipsychotics or recently (< 3 months) started on antidepressants. Patients on stable dose of antidepressant (for ≥ 3 months) will be allowed.
  • Have a lifetime history of schizophrenia
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01047917
07-006601
No
Dietlind Wahner-Roedler, Mayo Clinic
Mayo Clinic
Not Provided
Principal Investigator: Dietlind L. Wahner-Roedler, M.D. Mayo Clinic
Mayo Clinic
January 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP